Search results
PROMOTED
Start date:
Jun 10, 2026
Transcatheter edge-to-edge repair (TEER) is rapidly emerging as an important treatment option for patients with tricuspid regurgitation. Successful procedures require a detailed understanding of tricuspid valve anatomy, precise imaging guidance, and thoughtful procedural planning—especially in complex anatomies.This webinar brings together leading experts Prof Andrew Cook (UCL Institute…
View more
Added:
1 year ago
EuroPCR 25 - Post-hoc anlysis outcomes from under-expansion of the ACURATE neo2 valve in severe aortic stenosis (AS) patients show under-expansion was associated with higher rates of death, stroke or rehospitalisation.We are joined by Dr Raj Makkar (Cedars-Sinai Heart Institute, Los Angeles, US) to discuss findings from the post-hoc analysis of the ACURATE IDE study (NCT03735667; Boston…
View more
Added:
2 years ago
In this insightful interview, Dr Joanna J Wykrzykowska (University of Groningen, Groningen, NL), Prof Holger Thiele (Heart Center Leipzig at University of Leipzig, Leipzig, DE), and Prof Helge Möllmann (St Johannes Hospital, Dortmund, DE) discuss the findings and implications of the PROVE Registry, a comprehensive multi-centre all-comers study focused on the ACURATE neo2 transcatheter aortic…
View more
Added:
10 months ago
Source:
Radcliffe Cardiology
A post hoc analysis of the ACURATE IDE trial has found that underexpansion of the ACURATE neo2 transcatheter heart valve (THV) was associated with a higher rate of adverse clinical outcomes at one year.¹ The original trial failed to demonstrate non-inferiority of the ACURATE neo2 valve compared with contemporary commercial valves for the primary endpoint of all-cause mortality, stroke, or…
View more
Added:
11 months ago
New York Valves 2025 -Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and…
View more
Added:
2 weeks ago
Dr Virag Kushwaha (Eastern Heart Clinic, New South Wales, AU) joins us to discuss 30-day outcomes of valve-in-valve transcatheter aortic valve replacement using the Navitor system in patients with failed surgical aortic bioprosthetic valves.As the population of patients with ageing surgical bioprostheses continues to grow, valve-in-valve TAVR has become an increasingly important treatment pathway…
View more
Aortic Valve Calcium, Aortic Stenosis and TAVI
Added:
1 year ago
Review Article
Added:
11 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result…
View more
Choice of Transcatheter Aortic Valve Prosthesis
Added:
6 months ago
Review Article
Added:
11 months ago
New York Valves 2025 - Echocardiographic outcomes from the TRISCEND II substudy reinforce the effectiveness of TTVR compared to medical therapy alone at one year post transcatheter tricuspid valve replacement (TTVR).Dr Paul Grayburn (Baylor Scott and White Research Institute, Dallas, US) joins us to discuss echocardiographic outcomes one year post TTVR from the TRISCEND II substudy which…
View more